Fig. 1. Schematic illustration of the experimental protocol used in infarct size experiments. 5-HD = 5-hydroxydecanoic acid; CHE = chelerythrine; εV1–2 = protein kinase C-εV1–2 peptide; ISO = isoflurane; LAV = lavendustin A; MAC = minimum alveolar concentration; NAC =N -acetylcysteine; OCC = occlusion; PP1 = 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; ROT = rottlerin.